Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

neo315

K-Number: K231133 · 2024-07-22

Decision Date2024-07-22
Product CodeLNH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

neo315 is the device name listed in this FDA 510(k) record. The listed applicant is Neoscan Solution GmbH. It received FDA 510(k) clearance on 2024-07-22 under 510(k) number K231133. The device is classified under product code LNH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the neo315?

neo315 is a medical device that received FDA 510(k) clearance on 2024-07-22. The listed applicant is Neoscan Solution GmbH. The 510(k) number is K231133.

When did neo315 receive FDA 510(k) clearance?

neo315 received FDA 510(k) clearance on 2024-07-22, under 510(k) number K231133.

Who is the listed applicant for neo315?

The FDA 510(k) record lists Neoscan Solution GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for neo315?

The FDA product code for neo315 is LNH.

Related Devices (Code: LNH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.